Holen Sie sich die Stockscreener-App
2.53
3.07%
-0.08
Vorhandelsmarkt:
2.52
-0.010
-0.40%
C 4 Therapeutics Inc Aktie (CCCC) Neueste Nachrichten
C4 Therapeutics Inc. Bounces Off Moving Average Support2025 Historical Comparison & Safe Capital Growth Plans - thegnnews.com
Using Bollinger Bands to evaluate C4 Therapeutics Inc.2025 Big Picture & AI Powered Trade Plan Recommendations - Newser
Visual trend scoring systems applied to C4 Therapeutics Inc.Quarterly Profit Review & Capital Efficiency Focused Strategies - Newser
Is C4 Therapeutics Inc. forming a reversal patternTrade Risk Summary & Low Drawdown Trading Strategies - Newser
Detecting support and resistance levels for C4 Therapeutics Inc.July 2025 Action & Fast Entry and Exit Trade Plans - Newser
Market reaction to C4 Therapeutics Inc.’s recent newsMarket Risk Analysis & Smart Allocation Stock Reports - Newser
What analysts say about C4 Therapeutics Inc. stock outlookWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - Newser
Stoke Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
Real time breakdown of C4 Therapeutics Inc. stock performanceJuly 2025 Decliners & Fast Exit Strategy with Risk Control - Newser
What the charts say about C4 Therapeutics Inc. todayWeekly Loss Report & Reliable Price Breakout Alerts - Newser
C4 Therapeutics Inc. Breakout Confirmed by Volume MetricsVolume Spike & Entry Point Confirmation Signals - beatles.ru
How does C4 Therapeutics Inc. compare to its peersJuly 2025 Pullbacks & Real-Time Sentiment Analysis - thegnnews.com
Is C4 Therapeutics Inc. stock ready for a breakout2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
How hedge fund analytics apply to C4 Therapeutics Inc. stockRecession Risk & Low Risk High Reward Ideas - Newser
Long term hold vs stop loss in C4 Therapeutics Inc.July 2025 Update & Short-Term Swing Trade Alerts - Newser
What is the dividend yield of C4 Therapeutics Inc.Quarterly Portfolio Review & Free Fast Gain Swing Trade Alerts - thegnnews.com
XTX Topco Ltd Makes New Investment in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World
How institutional ownership impacts C4 Therapeutics Inc. stock2025 Trading Recap & Risk Controlled Stock Alerts - Newser
How to manage a losing position in C4 Therapeutics Inc.2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Why is C4 Therapeutics Inc. stock going downDay Trading 5x Gain Picks - mustnews.co.kr
Akamis Bio Announces the Appointment of Andrew Hirsch to the Company’s Board of Directors - Business Wire
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Why C4 Therapeutics Inc. stock attracts strong analyst attentionStock Forecast Tools for Retail Traders - Newser
Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
What earnings revisions data tells us about C4 Therapeutics Inc.Free Growth Based Investment Plan Guidance - Newser
How to integrate C4 Therapeutics Inc. into portfolio analysis toolsWeekly Gain Forecast with Momentum Indicators - Newser
New Product Launches: Will They Boost C4 Therapeutics Inc. Stock in 2025Smart Swing Picks with Confirmed Signals - Newser
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics 2025 Q2 Earnings Widened Losses Amid Mixed Price Performance - AInvest
Spotlight On 3 Intriguing Penny Stocks With Market Caps As Low As $100M - simplywall.st
C4 Therapeutics, Inc. (NASDAQ:CCCC) Surges 51% Yet Its Low P/S Is No Reason For Excitement - 富途牛牛
C4 Therapeutics Reports Q2 2025 Financial Results - TipRanks
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics Q2 2025 Financial Results: Revenue Down to $6.5M, Cash Position at $223M - AInvest
C4 Therapeutics shares surge 22.96% intraday after positive clinical trial results and strong Q2 earnings. - AInvest
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
C4 Therapeutics, Inc. SEC 10-Q Report - TradingView
C4 Therapeutics reports Q2 2025 results, cemsidomide Phase 1 data accepted at IMS. - AInvest
C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire
C4 Therapeutics shares rise 1.02% premarket after Ono Pharmaceutical's ESG index selection. - AInvest
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics (CCCC) Projected to Post Quarterly Earnings on Thursday - Defense World
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Astria Therapeutics Grants Stock Options to Two New Employees Under Nasdaq Listing Rule 5635(c)(4) - AInvest
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 4, 2025 - BioSpace
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewswire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Viridian Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
What drives C4 Therapeutics Inc. stock priceBuild wealth faster with disciplined trading - Jammu Links News
Is it the right time to buy C4 Therapeutics Inc. stockGet daily updates on promising stocks - Jammu Links News
What makes C4 Therapeutics Inc. stock price move sharplyCapitalize on momentum-driven stocks - Jammu Links News
1.38%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):